Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Mutat Res ; 191(2): 93-7, 1987 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-3110615

RESUMO

Clastogenic adaptation to TEM or MH no longer occurred when benzamide, an inhibitor of nuclear ADP-ribosyltransferase (ADPRT), was applied prior to the low dose (conditioning) treatment which triggers this phenomenon. This may be indicative that inducible processes connected with ribosylation reactions are involved in the protective effects exerted by clastogenic adaptation. No increase by benzamide pretreatment was observed in the yield of metaphases with TEM- or MH-induced chromatid aberrations after conditioning and challenge treatment, respectively. High benzamide concentrations (1 h, 5 X 10(-3) M) exerted protective effects against TEM challenging but not against MH.


Assuntos
Benzamidas/farmacologia , Cromátides/efeitos dos fármacos , Fabaceae/efeitos dos fármacos , Hidrazida Maleica/farmacologia , Plantas Medicinais , Piridazinas/farmacologia , Trietilenomelamina/farmacologia , Testes de Mutagenicidade , Inibidores de Poli(ADP-Ribose) Polimerases
2.
Mutat Res ; 149(3): 451-61, 1985 May.
Artigo em Inglês | MEDLINE | ID: mdl-3990696

RESUMO

Chinese hamster V79 cells were pulse-treated (for 60 min) with various mutagens three, two or one cell cycles before fixation (treatment variants A, B and C, respectively) and the frequencies of induced SCEs were analysed and compared. The degree of increase in frequency of SCEs with dose in the treatment variants depended on the mutagen used. For the methylating agents MNU, MNNG and DMPNU, high yields of SCEs were obtained in the treatment variants A and B, and there was no difference in the efficiency with which these agents induced SCEs in these treatment variants. In the treatment variant C, however, no SCEs were induced with mutagen doses yielding a linear increase in SCE frequency in treatment variants A and B. A slight increase in SCE frequency in treatment variant C was observed only when relatively high doses of MNU or MNNG were applied. Like the above agents, EMS, ENU and MMS induced more SCEs in treatment variants A and B than in C, but for these agents treatment variant B was most effective and SCEs were induced over the entire dose range, also in treatment variant C. As opposed to the methylating and ethylating agents, MMC induced SCEs with high efficiency when treatment occurred one or two generations prior to fixation. There was no difference in SCE frequency between these treatment variants. MMC was completely ineffective for the induction of SCEs when treatment occurred three generations before fixation. The unexpectedly low SCE frequencies induced by the methylating and ethylating agents when treatment occurred one generation before fixation were not due to the exposure of cells to BrdU prior to mutagen treatment. From the results obtained, it is concluded that DNA methylation and ethylation lesions give rise to SCEs only with very low probability during the replication cycle after the lesion's induction, and that subsequent lesions produced during or after replication of the methylated or ethylated template (secondary lesions) are of prime importance for SCE formation after alkylation. For MMC, however, primary lesions seem to be most important for SCE induction.


Assuntos
Alquilantes/toxicidade , Troca de Cromátide Irmã/efeitos dos fármacos , Alquilantes/administração & dosagem , Animais , Bromodesoxiuridina/toxicidade , Ciclo Celular , Linhagem Celular , Cricetinae , Cricetulus , Replicação do DNA , Esquema de Medicação , Fixadores , Metilação , Metilnitronitrosoguanidina/toxicidade
4.
Mutat Res ; 115(2): 149-73, 1983 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-6406880

RESUMO

EDTA and its salts have a number of applications in medicine and pharmacy. EDTA is used to remove calcium from the human body, and serves as an anticoagulant and as a detoxicant after poisoning by heavy metals. It is often used in analytical chemistry for complexometric titrations and many other purposes. Because the compound is of rather low toxicity, it is used as a food additive to bind metal ions. EDTA affects the inhibition of DNA synthesis in primary cultures of mammalian cells. This may be due to impairment of enzymes involved in DNA replication. Some early studies have shown that EDTA leads to morphological changes of chromatin and chromosome structure in plant and animal cells. These alterations consist of dispersion or swelling of chromosomes or a loss of interphase chromatin structure. For several test systems, a low chromosome-breaking activity of EDTA has been reported. A weak activity in the induction of gene mutations has also been observed. It is well established that EDTA influences chromosome breakage by mutagenic agents. In particular, when applied in combination with chemical mutagens, EDTA enhances mutagen-induced aberration frequencies. Furthermore, the chelating agent is able to increase the incidence of meiotic crossing-over. This has been demonstrated for many gene loci in Drosophila melanogaster, Chlamydomonas reinhardi, Neurospora crassa and Zea mays. EDTA interferes with DNA repair processes that take place after exposure to mutagens. In E. coli or Micrococcus radiodurans as well as in Chinese hamster cells, the fast repair component detectable after treatment with ionizing radiation or bleomycin is inhibited by EDTA. In plant cells exposed to gamma-rays, EDTA inhibits unscheduled DNA synthesis. The mechanism by which EDTA causes these effects remains poorly understood. The sequestering of metal ions by the chelating agent is obviously responsible for functional and structural alterations of the genetic material. Although EDTA produces a whole set of genetic effects it seems to be a harmless compound to man as far as genotoxicity is concerned. The data presently at hand, however, are not sufficient for a reliable risk assessment.


Assuntos
Ácido Edético/toxicidade , Mutagênicos , Mutação , Animais , Aberrações Cromossômicas , Cromossomos/efeitos dos fármacos , Cromossomos/fisiologia , Reparo do DNA , Meiose/efeitos dos fármacos , Mitose/efeitos dos fármacos , Plantas/efeitos dos fármacos , Especificidade da Espécie
6.
Eur J Biochem ; 96(2): 321-9, 1979 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-456377

RESUMO

In cotyledon cells of developing field beans the RNA content per cell does not change in the second half of developmental period 2, whereas globulin biosynthesis continues. The constant RNA content per cell results from an equilibrium between RNA synthesis and degradation. All types of RNA are synthesized until the end of globulin biosynthesis, but poly(A)-containing RNA was preferentially labelled during maximum globulin formation. During stage 2 of seed development of poly(A)-containing RNA fraction represents a discrete peak in the 12--18-S region on agarose gels and corresponds to the peak of poly(A)-containing RNA isolated from polysomes. alpha-Amanitin inhibits selectively the labelling of poly(A)-containing RNA and concomitantly globulin formation. Translation of total poly(A)-containing RNA, free and membrane-bound polysomes in a cell-free wheat germs demonstrates that the globulins are preferentially produced on membrane-bound polysomes and that poly(A)-containing RNA includes the mRNA for both vicilin and legumin.


Assuntos
Globulinas/biossíntese , Plantas/metabolismo , Polirribossomos/metabolismo , Biossíntese de Proteínas , RNA Ribossômico/metabolismo , Amanitinas/farmacologia , Imunoeletroforese Bidimensional , Cinética , Desenvolvimento Vegetal , Plantas/efeitos dos fármacos , Poli A/metabolismo , Biossíntese de Proteínas/efeitos dos fármacos , Triticum/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...